Fireside Chat: Targeting the DDR in Brain Tumors: Trials, Tribulations, & Future Directions
Time: 5:00 pm
day: Day One
Details:
- What evidence supports DDR as a therapeutic target in brain tumors, and are there specific subtypes where it shows more promise?
- Why have DDR-targeting therapies, including PARP inhibitors, faced limited success in brain tumor treatments despite their efficacy in other cancers?
- What strategies could overcome current barriers in DDR targeted therapy for brain tumors and enhance the efficacy of existing treatments?
